Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity

Meyrier, 2005, Mechanisms of disease: focal segmental glomerulosclerosis, Nat Clin Pract Nephrol, 1, 44, 10.1038/ncpneph0025 Fine, 2007, Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children, Pediatr Nephrol, 22, 496, 10.1007/s00467-006-0361-6 Hoyer, 2001, Recurrence of idiopathic nephrotic syndrome after renal transplantation, J Am Soc Nephrol, 12, 1994, 10.1681/ASN.V1291994 Artero, 1994, Plasmapheresis reduces proteinuria, serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis, Am J Kidney Dis, 23, 574, 10.1016/S0272-6386(12)80381-7 Haas, 1998, Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis, Nephrol Dial Transplant, 13, 2013, 10.1093/ndt/13.8.2013 Gohh, 2005, Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients, Am J Transplant, 5, 2907, 10.1111/j.1600-6143.2005.01112.x Savin, 1996, Circulating factor increasing glomerular permeability in recurrent focal segmental glomerulosclerosis, N Engl J Med, 334, 878, 10.1056/NEJM199604043341402 Sharma, 2002, Proteinuria after injection of human focal sclerosis factor, Transplantation, 73, 366, 10.1097/00007890-200202150-00009 Sharma, 2004, The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects, Exp Biol Med, 229, 85, 10.1177/153537020422900111 Savin, 1992, Measurement of albumin reflection coefficient with isolated rat glomeruli, J Am Soc Nephrol, 3, 1260, 10.1681/ASN.V361260 Aggarwal, 2007, Serum permeability activity (Palb) in minimal change nephrotic syndrome is permanently lost after successful treatment of Hodgkin's disease, Am J Kidney Dis, 50, 826, 10.1053/j.ajkd.2007.06.021 Cattran, 2003, Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis, J Am Soc Nephrol, 14, 448, 10.1097/01.ASN.0000046960.57614.17 Feld, 1998, Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys, Am J Kidney Dis, 32, 230, 10.1053/ajkd.1998.v32.pm9708606 Schmieder, 2004, Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells, J Am Soc Nephrol, 15, 2289, 10.1097/01.ASN.0000135968.49899.E8 Weigel, 2002, Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors, Biochim Biophys Acta, 1572, 341, 10.1016/S0304-4165(02)00318-5 Frustaci, 2001, Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy, N Engl J Med, 345, 25, 10.1056/NEJM200107053450104